A trial to assess the safety of nebulised heparin for acute lung injury

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000388516

Enrollment

Registered

2006-09-05

Start date

2006-08-30

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To assess whether nebulised heparin limits the extent of lung injury in patients with, or at risk of the acute respiratory distress syndrome.

Interventions

Nebulised Heparin 25,000 U bd in normal saline. Given 12 hourly for 2 days.

Study design

Allocation

Non-randomised trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

Acute lung injurymechanical ventilation.

Exclusion criteria

Systemic heparin administrationPulmonary haemorrhage.

Outcome results